Ileana O Jelescu1, Magdalena Zurek1, Kerryanne V Winters1, Jelle Veraart1, Anjali Rajaratnam1, Nathanael S Kim1, James S Babb1, Timothy M Shepherd1, Dmitry S Novikov1, Sungheon G Kim1, and Els Fieremans1
1Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, NY, United States
Synopsis
White Matter Tract Integrity (WMTI) metrics
derived from diffusion data provide a compartment-specific characterization of
white matter. Here, we evaluated the specificity of the axonal water fraction
(AWF) and extra-axonal radial diffusivity (De,┴) by
assessing their correlations to metrics derived from electron microscopy (EM),
in the splenium of control, cuprizone-treated and recovering mice. As the model
predicted, the WMTI-derived AWF correlated very strongly with the EM-derived
AWF, but not with the g-ratio, while De,┴
correlated with the g-ratio, but not with the EM-derived AWF. WMTI
parameters are therefore promising biomarkers for specific biophysical aspects
of white matter pathology in vivo.Purpose
Monitoring of myelin damage and repair is of
great clinical importance for demyelinating diseases. Conventional MRI measures (e.g.
T2, MTR and radial
diffusivity (RD)) are sensitive, but non-specific to the WM injury, whereas WM
tract integrity (WMTI) metrics
1 derived from diffusion kurtosis
imaging (DKI) can provide compartment specific estimates of WM properties, such
as axonal water fraction (AWF) and extra-axonal radial diffusivity (
De,┴) (Fig. 1). Cuprizone fed mice provide an excellent model of demyelination
2.
In vivo changes in both conventional MRI measures and WMTI parameters during cuprizone-induced demyelination and subsequent recovery were previously reported in the mouse corpus callosum
3-5. Here, we examine the correlations between WMTI parameters and electron microscopy (EM) measures.
Methods
We conducted an 18-week longitudinal study on 34 female C57
mice (8 weeks old at baseline) separated into 3 groups: "Control"
group received standard chow; "Cpz6" and "Cpz12" groups
received cuprizone for 6 and 12 weeks, respectively (Fig. 2).
MRI:
In vivo MRI was performed using a 7-T Bruker BioSpec system. Diffusion-weighted
images of one 0.8-mm thick mid-sagittal slice were acquired (
b=1000 and 2000
s/mm
2, 30 directions each, and 6
b=0 images) at 112-μm in-plane resolution. DKI analysis and derivation of the WMTI parameters were performed
1. The
splenium was segmented using a semi-automated in-house
software tool.
EM: Subsets of
animals were sacrificed and perfusion-fixed at 6, 12 and 18 weeks (Fig. 2). The brains were
extracted and further prepared for EM. Nanometer-thick
slices from the splenium were imaged using a Phillips CM12 transmission
electron microscope at 2.36 nm spatial resolution. Electron micrographs were
analyzed using in-house developed macros in ImageJ and CellProfiler. The EM
metrics extracted were myelin volume fraction (MVF), myelinated axon volume
fraction (mAVF) and total axonal volume fraction (tAVF). An
"aggregate"
g-ratio was derived as $$$\sqrt{tAVF/(MVF+tAVF)}$$$. Because there is a
conceptual difference between AVF and AWF (the former refers to a volume fraction,
the latter is a fraction of "MR visible" water, which does not
account for the myelin space), the EM-derived $$$mAWF=mAVF/(1-MVF)$$$ and $$$tAWF=tAVF/(1-MVF)$$$ were further calculated. The EM image analysis
was performed for three randomly chosen mice per timepoint and diet group, and eight micrographs per animal, resulting
in 423 myelinated and 1623 unmyelinated axons processed on average per animal.
Correlations: The mean and standard
deviation in the splenium were calculated for all MRI and EM measures in each
animal. Partial Spearman correlations (ρ) were calculated between the MRI and the EM
measures, using mouse weight at baseline as a covariate. A linear (Pearson) correlation
(r) was also computed between WMTI-derived AWF and EM-derived tAWF to evaluate their direct agreement.
Results and Discussion
All EM and MRI measures were consistent with expected trends of cuprizone intoxication and recovery at all timepoints (Figs. 3 and 4). Acute cuprizone exposure (6 weeks) was characterized by "patchy" demyelination (Figs. 1C and 3A) and significant decrease in AWF, and chronic exposure (12 weeks) by widespread demyelination and significant increase in De,┴.
Correlations are summarized in
Figure 5. RD correlated significantly with EM-derived MVF,
mAWF, tAWF and g-ratio. Among
WMTI metrics, the AWF correlated most strongly with tAWF,
followed by mAWF and MVF; AWF did not correlate significantly with the g-ratio (although a trend was present). Conversely, De,┴ correlated
most strongly with MVF and g-ratio; De,┴ did not correlate significantly
with mAWF and tAWF.
The correlations are consistent with results from previous simulations6, which suggest AWF is particularly sensitive to random axonal loss and/or patchy demyelination, while De,┴ is particularly sensitive to homogeneous demyelination, and hence to the g-ratio .
The WMTI-derived AWF is by design a measure of the same quantity as the
EM-derived tAWF. Remarkably, the two measures exhibited a very strong linear correlation, and their relationship
was well fit by a linear model with a quasi-zero intercept (0.014 ±
0.120). The slope however
was not unity (0.58 ± 0.17), indicative of a scaling effect between the two modalities. One
explanation for this scaling could be non-linear shrinkage caused by chemical
fixation in the EM images: the extra-axonal space shrank more than the
intra-axonal space. Another explanation, this time affecting AWFWMTI,
could be a higher transverse relaxation rate in the intra- vs. the extra-axonal
space7 which would introduce a non-negligible $$$e^{-TE\cdot\Delta R_{2}}$$$ weighting.
Conclusions
The correlations
between EM and WMTI metrics support the specificity associated with AWF
and
De,┴ as expected from the model. The WMTI model parameters can be derived from data
acquired in under ten minutes on clinical scanners, and are therefore promising candidates as sensitive and
specific biomarkers for routine
monitoring of microstructural changes in demyelinating pathologies.
Acknowledgements
This work was supported by the NIH grant R21 NS081230.References
1. Fieremans et al., Neuroimage 2011, 58(1):177-88.
2. Matsushima and Morell, Brain Pathol 2001, 11(1):107-16.
3. Falangola et al., NMR in Biomed 2014, 27(8):948-57.
4. Jelescu et al., Proc of the ISMRM 2015, p. 3000.
5. Guglielmetti et al., Neuroimage 2015, 125:363-377.
6. Novikov and Fieremans, Proc of the ISMRM 2012, p. 1829.
7. Beaulieu et al., Magn Reson Imaging 1998, 16(10):1201-10.